-
21
Adjustable Maintenance Dosing with Budesonide/Formoterol Reduces Asthma Exacerbations Compared with Traditional Fixed Dosing: A Five-Month Multicentre Canadian Study
Published 2003-01-01“…BACKGROUND: Adjustable maintenance dosing with budesonide/formoterol in a single inhaler (Symbicort, AstraZeneca, Lund, Sweden) may provide a convenient means of maintaining asthma control with the minimum effective medication level.…”
Get full text
Article -
22
Phospholipogenic Pharmaceuticals Are Associated with a Higher Incidence of Histological Findings than Nonphospholipogenic Pharmaceuticals in Preclinical Toxicology Studies
Published 2012-01-01“…To investigate the link between phospholipogenic administration and incidence of preclinical histological signals, an internal AstraZeneca in vivo toxicology report database was searched to identify phospholipogenic and nonphospholipogenic compounds. …”
Get full text
Article -
23
-
24
-
25
-
26
Orthogonal validation of PROTAC mediated degradation of the integral membrane proteins EGFR and c-MET
Published 2025-01-01Get full text
Article -
27
-
28
Erratum to “Overexpression of PGC-1 Increases Fatty Acid Oxidative Capacity of Human Skeletal Muscle Cells”
Published 2013-01-01Get full text
Article -
29
Development of Spray-Dried Micelles, Liposomes, and Solid Lipid Nanoparticles for Enhanced Stability
Published 2025-01-01Get full text
Article -
30
Efficacy of tezepelumab in patients with severe asthma and persistent airflow obstruction
Published 2024-11-01Get full text
Article -
31
Roles for Prlhr/GPR10 and Npffr2/GPR74 in feeding responses to PrRP
Published 2025-02-01Get full text
Article -
32
-
33
A thematic analysis of UK COVID-19 vaccine hesitancy discussions on Twitter
Published 2025-01-01“…Abstract Background Following UK approval of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on 2/12/20 and 30/12/20 respectively, discussions about them emerged on the social media platform Twitter, (now ‘X’). …”
Get full text
Article -
34
Characteristics of patients with undiagnosed stage 3 chronic kidney disease: results from an observational study (REVEAL-CKD) in ChinaResearch in context
Published 2025-01-01“…The improved prescription patterns and the attenuation of eGFR decline post-diagnosis demonstrate the importance of early diagnosis and timely intervention in CKD patients. Funding: AstraZeneca China.…”
Get full text
Article -
35
Cell clone selection—impact of operation modes and medium exchange strategies on clone ranking
Published 2025-01-01Get full text
Article -
36
AB ÜYE DEVLETLERİNDE COVID-19 AŞILARININ ÖN SATIN ALMA SÖZLEŞMELERİ İÇİN VİYANA SATIM ANTLAŞMASININ (CISG’İN) UYGULANABİLİRLİĞİ
Published 2022-08-01“…Avrupa Komisyonu, Avrupa Birliği’nde COVID-19 aşısının üretimi, satın alınması ve temini için çeşitli aşı üretici firmaları ile ön satın alma sözleşmesi imzalamıştır. AstraZeneca, Curevac Ag ve Pfizer Inc./BioNTech ile yapılan sözleşme metinlerinin bazı kısımları karartılarak yayımlanmıştır. …”
Get full text
Article -
37
-
38
Prevention of respiratory syncytial virus infection in children. Recommendations of the Polish Society of Paediatrics and the National Paediatric Consultant
Published 2024-12-01“…The monoclonal antibody nirsevimab (AstraZeneca and Sanofi Pasteur) is used in newborns and infants to protect against severe RSV infection. …”
Get full text
Article -
39
Vaccine diplomacy and the South African Sovereignty Maintenance Struggle within BRICS cooperation
Published 2023-07-01“…South Africa put more faith initially in AstraZeneca ahead of Sinopharm and Sinovac vaccines from China and Sputnik V from Russia. …”
Get full text
Article -
40
Investigating the pre- and post-COVID-19 vaccination infection status of Iranian dental students: a cross-sectional study
Published 2025-01-01“…Despite no significant difference in COVID-19 infection rates between genders, study years, or vaccine types (excluding AstraZeneca), participants who received the AstraZeneca vaccine experienced more serious side effects compared to those who received other vaccines. …”
Get full text
Article